Looking for our Business Solutions? Click here:CloudQuote APIsContact Us
Stocks in the NewsMost Active StocksPercent GainersPercent LosersFollowed Stocks
,

Latest News

Nvidia Is About 4% From Becoming the First $6 Trillion Company. History Says the Milestone Itself Tells You Little.fool.com
Five past trillion-dollar milestones were followed by five really different years. What separated the good ones from the bad?
Via The Motley Fool · October 6, 2026
Here's the Average Social Security Benefit at Age 65fool.com
Claiming Social Security at 65 triggers a permanent reduction that lasts your entire retirement, even as Medicare kicks in.
Via The Motley Fool · October 6, 2026
Byrna (BYRN) Reports Earnings Tomorrow: What To Expect
Non-lethal weapons company Byrna (NASDAQ:BYRN) will be reporting earnings this Thursday before market hours. Here’s what you need to know. Byrna missed analy...
Via StockStory · October 6, 2026
PepsiCo (PEP) Q3 Earnings Report Preview: What To Look For
Food and beverage company PepsiCo (NASDAQ:PEP) will be reporting results this Thursday before market open. Here’s what to look for. PepsiCo beat analysts’ re...
Via StockStory · October 6, 2026
Lamb Weston (LW) Q1 2027 Earnings Call Transcriptfool.com
North America volume growth outpaced market trends for a seventh straight quarter.
Via The Motley Fool · October 6, 2026
Apogee (APOG) Q2 2027 Earnings Call Transcriptfool.com
CEO Nolan raises full-year guidance on acquisition momentum and pricing strength.
Via The Motley Fool · October 6, 2026
The "Trumpflation" Trade Could Get Worse Before It Gets Better. History Says These 2 Stocks Are the Place to Hide.fool.com
People have long been willing to pay for healthcare despite rising costs, with Medtronic and Eli Lilly offering two different angles on the space.
Via The Motley Fool · October 6, 2026
Rocket Pharmaceuticals Details RP-A501 Pivotal Plan After Safety Resetmarketbeat.com
Rocket Pharmaceuticals (NASDAQ:RCKT) outlined updated clinical, regulatory and commercial plans for its investigational gene therapy RP-A501 in Danon disease, reporting longer-term Phase I findings, preliminary Phase II observations and an FDA-aligned pivotal study design. Chief Executive Officer G
Via MarketBeat · October 6, 2026
Nvidia Hits a New All-Time High. Is the AI Stock a Buy?fool.com
Nvidia just hit another record. It's closing in on $6 trillion.
Via The Motley Fool · October 6, 2026
AGCO’s $2 Billion PTx Bet: How Precision Tech Is Reshaping the Farmmarketbeat.com
AGCO (NYSE:AGCO) used its 2026 Technology Event to outline a long-term strategy centered on precision agriculture, mixed-fleet technology, data platforms and service delivered directly to farms. Chairman, President and Chief Executive Officer Eric Hansotia said the company remains fundamentally a m
Via MarketBeat · October 6, 2026
Novo Stock Is Down More Than 70% From Its Peak. Value Trap or Generational Buying Opportunity?fool.com
Novo Nordisk has a huge opportunity in GLP-1 weight-loss drugs, but it has to prove it can use that success to build for the future.
Via The Motley Fool · October 6, 2026
Is it Too Late to Buy Carnival Cruise Stock?fool.com
Consumers are making up for lost travel time.
Via The Motley Fool · October 6, 2026
How Big Does Your TFSA Need to Be to Pay $1,000 a Month?fool.ca
A TFSA yielding 6% would need roughly $200,000 to produce $1,000 in average monthly income.
Via The Motley Fool · October 6, 2026
Why Is DraftKings Stock Crashing, and is it a Buying Opportunity?fool.com
Competition is increasing for DraftKings.
Via The Motley Fool · October 6, 2026
Why Boost Run Stock Popped by Nearly 6% Todayfool.com
The company announced a splashy new AI cloud contract with an unnamed client.
Via The Motley Fool · October 6, 2026
Is Bloom Energy an Excellent AI Stock to Buy Right Now in October?fool.com
Demand for energy is soaring, and that's great news for Bloom Energy.
Via The Motley Fool · October 6, 2026
Applied Materials vs. Nvidia: What Revenue Trends Reveal About These Artificial Intelligence Companiesfool.com
Applied Materials held steady for most of two years before accelerating, while Nvidia's revenue nearly tripled over the same span.
Via The Motley Fool · October 6, 2026
Penguin Solutions Q4 Earnings Call Highlightsmarketbeat.com
Penguin Solutions (NASDAQ:PENG) reported record fourth-quarter results for fiscal 2026, driven by rising demand for AI infrastructure and data-center memory products, while raising its fiscal 2027 outlook for revenue and earnings. Fourth-quarter net sales rose 68% year over year to $567 million, wh
Via MarketBeat · October 6, 2026
Data Centres Need Power, but Higher Rates Change the Math: I’d Watch This TSX Stockfool.ca
The computers may be futuristic. Getting paid for supplying their electricity is pleasantly old-fashioned.
Via The Motley Fool · October 6, 2026
Why CrowdStrike Stock Ticked Higher on Tuesdayfool.com
Its upcoming industry conference is going to be a barn-burner.
Via The Motley Fool · October 6, 2026
Banco Bradesco Director Caffarelli Buys 31,266 Preference Shares. Is The Brazilian Bank Due to Rally?fool.com
Insider purchased shares at $17.98 each, well above the $3.43 market close on transaction date, signaling confidence despite recent valuation disconnect.
Via The Motley Fool · October 6, 2026
1 No-Brainer Artificial Intelligence (AI) ETF to Buy With $100 and Hold Foreverfool.com
Picking winners and losers in the artificial intelligence industry hasn't been easy.
Via The Motley Fool · October 6, 2026
Why Amphenol Stock Topped the Market on Tuesdayfool.com
Two analysts raised their price targets on the electronic components maker.
Via The Motley Fool · October 6, 2026
Cooper Companies Director Rosebrough Buys 10,000 Shares for $542,000. What Does His Move Say About This Eye Care Stock?fool.com
Insider purchased shares through his revocable trust following a 19% stock decline over the past year, doubling his indirect holdings to 20,000 shares.
Via The Motley Fool · October 6, 2026
What Neogen (NEOG) Said on Its Q1 Earnings Callmarketbeat.com
Neogen (NASDAQ:NEOG) reported fiscal 2027 first-quarter revenue of $222.8 million, with core growth of 8.1%, as the company cited improved commercial execution, product-line strength in food safety and animal safety, and progress on its Petrifilm manufacturing transition. Chief Executive Officer Mi
Via MarketBeat · October 6, 2026